Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ning Wan

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Molecular and Clinical Oncology|February 3, 2022
Expression of PD-L1 and CD4+ tumor-infiltrating lymphocytes predict survival in head and neck squamous cell carcinomaZe-Ming Fu, De-Jun Zhang, Ying-Yuan Guo, et al.
Frontiers in Microbiology|October 18, 2021
Whole-Genome and Transcriptome Sequencing of <i>Phlebopus portentosus</i> Reveals Its Associated Ectomycorrhizal Niche and Conserved Pathways Involved in Fruiting Body DevelopmentJia-Ning Wan, Yan Li, Ting Guo, et al.
Aging|August 26, 2019
Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinomaWen-Hao Xu, Yue Xu, Jun Wang, et al.
Oncotargets and Therapy|October 29, 2020
High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell CarcinomaJie Wu, Yu-Chen Wang, Wen-Hao Xu, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 12, 2019
The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell CarcinomaWen-Hao Xu, Shen-Nan Shi, Jun Wang, et al.
NPJ Precision Oncology|December 11, 2023
A deep learning model, NAFNet, predicts adverse pathology and recurrence in prostate cancer using MRIsWei-Jie Gu, Zheng Liu, Yun-Jie Yang, et al.
Aging|September 8, 2019
Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironmentWen-Hao Xu, Yue Xu, Jun Wang, et al.
Plos One|April 30, 2015
MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate CancerGui-Ming Zhang, Chun-Yang Bao, Fang-Ning Wan, et al.
Nature Chemical Biology|June 15, 2023
Chemoproteomic mapping of the glycolytic targetome in cancer cellsYang Tian, Ning Wan, Hanqing Zhang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 7, 2014
[Influence of obesity on clinicopathological characteristics in patients with clinically localized prostate cancer]Yuan-yuan Qu, Bo Dai, Kun Chang, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Molecular and Clinical Oncology|February 3, 2022
Expression of PD-L1 and CD4+ tumor-infiltrating lymphocytes predict survival in head and neck squamous cell carcinomaZe-Ming Fu, De-Jun Zhang, Ying-Yuan Guo, et al.
Frontiers in Microbiology|October 18, 2021
Whole-Genome and Transcriptome Sequencing of <i>Phlebopus portentosus</i> Reveals Its Associated Ectomycorrhizal Niche and Conserved Pathways Involved in Fruiting Body DevelopmentJia-Ning Wan, Yan Li, Ting Guo, et al.
Aging|August 26, 2019
Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinomaWen-Hao Xu, Yue Xu, Jun Wang, et al.
Oncotargets and Therapy|October 29, 2020
High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell CarcinomaJie Wu, Yu-Chen Wang, Wen-Hao Xu, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 12, 2019
The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell CarcinomaWen-Hao Xu, Shen-Nan Shi, Jun Wang, et al.
NPJ Precision Oncology|December 11, 2023
A deep learning model, NAFNet, predicts adverse pathology and recurrence in prostate cancer using MRIsWei-Jie Gu, Zheng Liu, Yun-Jie Yang, et al.
Aging|September 8, 2019
Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironmentWen-Hao Xu, Yue Xu, Jun Wang, et al.
Plos One|April 30, 2015
MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate CancerGui-Ming Zhang, Chun-Yang Bao, Fang-Ning Wan, et al.
Nature Chemical Biology|June 15, 2023
Chemoproteomic mapping of the glycolytic targetome in cancer cellsYang Tian, Ning Wan, Hanqing Zhang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 7, 2014
[Influence of obesity on clinicopathological characteristics in patients with clinically localized prostate cancer]Yuan-yuan Qu, Bo Dai, Kun Chang, et al.
Pageof 11